PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-218

  1. 4,249 Posts.
    lightbulb Created with Sketch. 6731
    Indeed we do need change and as immediately as possible.

    If left on the current trajectory there would be real danger we would be diluted into oblivion.

    Scott will indeed be quite a force for the positive for us.

    DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.